2008
DOI: 10.1101/sqb.2008.73.038
|View full text |Cite
|
Sign up to set email alerts
|

Generation of Cardiomyocytes from New Human Embryonic Stem Cell Lines Derived from Poor-quality Blastocysts

Abstract: Human embryonic stem (hES) cells represent a potential source for cell replacement therapy of many degenerative diseases. Most frequently, hES cell lines are derived from surplus embryos from assisted reproduction cycles, independent of their quality or morphology. Here, we show that hES cell lines can be obtained from poor-quality blastocysts with the same efficiency as that obtained from good-or intermediate-quality blastocysts. Furthermore, we show that the self-renewal, pluripotency, and differentiation ab… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
38
0

Year Published

2009
2009
2017
2017

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 45 publications
(38 citation statements)
references
References 50 publications
0
38
0
Order By: Relevance
“…6C), comparable with a human embryonic stem cell line (ES6) (35), showing that the obtained iPS cell lines had pluripotency properties similar to human embryonic stem cells.…”
Section: Generation Of Human Ips Cells After Transfection Of the Pcagmentioning
confidence: 65%
“…6C), comparable with a human embryonic stem cell line (ES6) (35), showing that the obtained iPS cell lines had pluripotency properties similar to human embryonic stem cells.…”
Section: Generation Of Human Ips Cells After Transfection Of the Pcagmentioning
confidence: 65%
“…The three human (h) ESC lines used, ES[2], ES [3] and ES [4], were derived as published (Aran et al, 2010;Raya et al, 2008) at the CMR [B]. Lowpassage cells of each line were thawed and cultured for one passage over a feeder layer of human foreskin fibroblasts (HFFs; CCD1112Sk ATCC, Manassas, VA, USA) in hES medium at 37°C and 5% CO 2 .…”
Section: Human Esc Culturementioning
confidence: 99%
“…These poor-quality embryos (PQEs) are typically discarded following treatment or donated for research after patient consent. Despite impaired implantation and developmental potential, PQEs have been shown to be a viable source for the derivation of new human embryonic stem cell (hESC) lines [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16]. It is estimated that hundreds of thousands of embryos per year are discarded because of poor quality and the majority of infertility patients are in favor of donating them for stem cell research [7,17,18].…”
Section: Introductionmentioning
confidence: 99%